Cargando…
Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future: Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011342/ http://dx.doi.org/10.1097/IM9.0000000000000056 |
Ejemplares similares
-
Retraction: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19
Publicado: (2022) -
Retracted: Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins
por: and Applications, Bioinorganic Chemistry
Publicado: (2023) -
Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat
SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022) -
Retraction: The Impact of Charlson Comorbidity Index on Mortality From SARS-CoV-2 Virus Infection
por: Ahmed, Jawad, et al.
Publicado: (2022) -
Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study
por: Obesity, Journal of
Publicado: (2022)